Menest

— THERAPEUTIC CATEGORIES —
  • Menopause and HRT
  • Prostate and other male cancers

Menest Generic Name & Formulations

General Description

Esterified estrogens 0.3mg, 0.625mg, 1.25mg, 2.5mg; tabs.

Pharmacological Class

Estrogen.

How Supplied

Tabs 2.5mg—50; 0.3mg, 0.625mg, 1.25mg—100

Manufacturer

Menest Indications

Indications

Moderate to severe vasomotor symptoms of menopause. Atrophic vaginitis. Kraurosis vulvae. Hypoestrogenism.

Menest Dosage and Administration

Adult

Menopause: 1.25mg daily, give cyclically (3 weeks on, 1week off); if menstruating use Day 5 start. Atrophic vaginitis, kraurosis vulvae: 0.3–1.25mg or more daily, give cyclically (3 weeks on, 1 week off). Hypogonadism: 2.5–7.5mg daily in divided doses for 20 days then stop for 10 days; repeat course if withdrawal bleeding does not occur within these 10 days. If bleeding occurs within 10 days, begin 20-day cyclic regimen adding an oral progestin. If bleeding occurs before this regimen is finished, discontinue therapy and may resume on Day 5 of bleeding. Female castration, primary ovarian failure: 1.25mg daily, cyclically. Reevaluate periodically.

Children

Not applicable.

Menest Contraindications

Contraindications

Thrombophlebitis. Thromboembolic disorders. Cerebrovascular or coronary artery disease. Pregnancy (Cat.X).

Menest Boxed Warnings

Not Applicable

Menest Warnings/Precautions

Warnings/Precautions

Hepatic dysfunction. Gallbladder disease. Conditions aggravated by fluid retention. Familial hyperlipoproteinemia. Discontinue if jaundice occurs. Nursing mothers.

Menest Pharmacokinetics

See Literature

Menest Interactions

Not Applicable

Menest Adverse Reactions

Adverse Reactions

See literature. Breakthrough bleeding, dysmenorrhea, mastodynia, migraine, depression, edema, weight changes, hypertension, GI upset.

Menest Clinical Trials

See Literature

Menest Note

Not Applicable

Menest Patient Counseling

See Literature

Menest Generic Name & Formulations

General Description

Esterified estrogens 0.3mg, 0.625mg, 1.25mg, 2.5mg; tabs.

Pharmacological Class

Estrogen.

How Supplied

Tabs 2.5mg—50; 0.3mg, 0.625mg, 1.25mg—100

Manufacturer

Menest Indications

Indications

Palliative treatment of androgen-dependent advanced prostate cancer.

Menest Dosage and Administration

Adult

1.25–2.5mg 3 times daily.

Children

Not applicable.

Menest Contraindications

Contraindications

Thrombophlebitis. Thromboembolic disorders. Cerebrovascular or coronary artery disease. Pregnancy (Cat.X).

Menest Boxed Warnings

Not Applicable

Menest Warnings/Precautions

Warnings/Precautions

Hepatic dysfunction. Gallbladder disease. Conditions aggravated by fluid retention. Familial hyperlipoproteinemia. Discontinue if jaundice occurs. Nursing mothers.

Menest Pharmacokinetics

See Literature

Menest Interactions

Not Applicable

Menest Adverse Reactions

Adverse Reactions

See literature. Migraine, depression, edema, weight changes, hypertension, GI upset, gynecomastia, impotence.

Menest Clinical Trials

See Literature

Menest Note

Not Applicable

Menest Patient Counseling

See Literature